Opinions
Pat Naccarato
Bausch & Lomb Inc.
BOL-N
HOLD
Apr 26, 2007
Had a misstep on a contact lens solution and the stock dropped to the mid-$40's. He bought at that level, because even if all of their contact lens solution went to zero, they still had other businesses. Recent rumours have driven the stock up to $60.
$59.510
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
TOP PICK
Has gone through a transition. Was suffering a few years ago when it lost its momentum, R&D lagged. Can see some growth opportunity in their new lens. New president has shaken down the company, cut costs and re-invigorated their R&D. Has exceeded expectations for 13 quarters.
biotechnology
pharmaceutical
Advertising